Humacyte, Inc. Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -0.70M-3.08M-4.63M-6.60M-9.28M
Gross Profit -0.70M-3.08M-4.63M-6.60M-9.28M
Operating items
Research & Development 54.08M61.34M63.26M76.55M88.60M
Selling, General & Administrative 12.01M21.13M22.88M23.50M25.80M
Operating Expenses 66.09M82.47M86.14M100.05M114.40M
Operating Income -64.60M-81.21M-84.60M-100.05M-114.40M
EBIT -64.60M-81.21M-84.60M-100.05M-114.40M
Non-operating items
Interest & Investment Income 0.28M0.02M2.63M5.47M4.10M
Other Non Operating Income 3.28M0.42M-2.42M3.92M
Non Operating Income -1.92M54.73M72.61M-10.73M-34.30M
Net income details
EBT -66.52M-85.54M-88.17M-101.18M-119.57M
Profit After Tax -66.52M-26.48M-11.96M-110.78M-148.70M
Income from Continuing Operations -66.52M-85.54M-88.17M-101.18M-119.57M
Consolidated Net Income -66.52M-85.54M-88.17M-101.18M-119.57M
Income towards Parent Company -66.52M-85.54M-88.17M-101.18M-119.57M
Net Income towards Common Stockholders -66.52M-85.54M-88.17M-101.18M-119.57M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 12.86M103.00M103.12M103.58M125.86M
EBITDA -66.52M-26.48M-11.96M-110.78M-148.70M